blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2373626

EP2373626 - SUBSTITUTED INDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  30.06.2017
Database last updated on 15.06.2024
Most recent event   Tooltip21.09.2018Lapse of the patent in a contracting state
New state(s): MT		published on 24.10.2018  [2018/43]
Applicant(s)For all designated states
Nerviano Medical Sciences S.r.l.
Viale Pasteur, 10 P.O. Box 11
20014 Nerviano (MI) / IT
[2016/12]
Former [2011/41]For all designated states
Nerviano Medical Sciences S.r.l.
11 Viale Pasteur, 10 P.O. Box 11
20014 Nerviano (MI) / IT
Inventor(s)01 / MENICHINCHERI, Maria
Via Felice Casati 19
I-20124 Milan / IT
02 / BERTRAND, Jay, Aaron
Via B. Colleoni 37
I-20020 Villa Cortese (MI) / IT
03 / MARCHIONNI, Chiara
Via Lucca 18
I-20152 Milan / IT
04 / NESI, Marcella
Via Brianza 57
I-21047 Saronno (VA) / IT
05 / ORSINI, Paolo
Via Padova 5
I-20025 Legnano (MI) / IT
06 / PANZERI, Achille
Via G.Matteotti 8
I-23807 Merate (LC) / IT
 [2011/41]
Representative(s)(deleted)
[2011/41]
Application number, filing date09768400.515.12.2009
[2016/34]
WO2009EP67206
Priority number, dateEP2008017209118.12.2008         Original published format: EP 08172091
[2011/41]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010069966
Date:24.06.2010
Language:EN
[2010/25]
Type: A1 Application with search report 
No.:EP2373626
Date:12.10.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 24.06.2010 takes the place of the publication of the European patent application.
[2011/41]
Type: B1 Patent specification 
No.:EP2373626
Date:24.08.2016
Language:EN
[2016/34]
Search report(s)International search report - published on:EP24.06.2010
ClassificationIPC:C07D231/56, C07D401/12, C07D401/14, C07D403/12, C07D405/12, A61K31/416, A61K31/454, A61K31/496, A61P35/00
[2011/41]
CPC:
C07D405/12 (EP,US); A61P11/00 (EP); A61P17/06 (EP);
A61P19/02 (EP); A61P27/02 (EP); A61P3/00 (EP);
A61P3/04 (EP); A61P35/00 (EP); A61P43/00 (EP);
A61P9/10 (EP); C07D231/56 (EP,US); C07D401/12 (EP,US);
C07D401/14 (EP,US); C07D403/12 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2016/34]
Extension statesALNot yet paid
BANot yet paid
RSNot yet paid
TitleGerman:SUBSTITUIERTE INDAZOLDERIVATE, DIE ALS KINASEINHIBITOREN WIRKEN[2011/41]
English:SUBSTITUTED INDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS[2011/41]
French:DÉRIVÉS D'INDAZOLE SUBSTITUÉS ACTIFS EN TANT QU'INHIBITEURS DE KINASES[2011/41]
Entry into regional phase06.07.2011National basic fee paid 
06.07.2011Designation fee(s) paid 
06.07.2011Examination fee paid 
Examination procedure06.07.2011Amendment by applicant (claims and/or description)
06.07.2011Examination requested  [2011/41]
18.06.2012Despatch of a communication from the examining division (Time limit: M04)
20.09.2012Reply to a communication from the examining division
21.10.2013Despatch of a communication from the examining division (Time limit: M04)
27.02.2014Reply to a communication from the examining division
10.08.2015Despatch of a communication from the examining division (Time limit: M04)
30.11.2015Reply to a communication from the examining division
23.02.2016Communication of intention to grant the patent
07.06.2016Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
08.06.2016Fee for grant paid
08.06.2016Fee for publishing/printing paid
19.07.2016Information about intention to grant a patent
19.07.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  18.06.2012
Opposition(s)26.05.2017No opposition filed within time limit [2017/31]
Fees paidRenewal fee
27.12.2011Renewal fee patent year 03
29.04.2013Renewal fee patent year 04
27.05.2014Renewal fee patent year 05
29.12.2014Renewal fee patent year 06
28.12.2015Renewal fee patent year 07
Penalty fee
Additional fee for renewal fee
31.12.201204   M06   Fee paid on   29.04.2013
31.12.201305   M06   Fee paid on   27.05.2014
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU15.12.2009
AT24.08.2016
BE24.08.2016
CY24.08.2016
CZ24.08.2016
DK24.08.2016
EE24.08.2016
FI24.08.2016
HR24.08.2016
IS24.08.2016
LT24.08.2016
LV24.08.2016
MC24.08.2016
MK24.08.2016
NL24.08.2016
PL24.08.2016
RO24.08.2016
SE24.08.2016
SI24.08.2016
SK24.08.2016
SM24.08.2016
TR24.08.2016
BG24.11.2016
NO24.11.2016
GR25.11.2016
LU15.12.2016
MT15.12.2016
PT26.12.2016
[2018/43]
Former [2018/30]HU15.12.2009
AT24.08.2016
BE24.08.2016
CY24.08.2016
CZ24.08.2016
DK24.08.2016
EE24.08.2016
FI24.08.2016
HR24.08.2016
IS24.08.2016
LT24.08.2016
LV24.08.2016
MC24.08.2016
MK24.08.2016
NL24.08.2016
PL24.08.2016
RO24.08.2016
SE24.08.2016
SI24.08.2016
SK24.08.2016
SM24.08.2016
TR24.08.2016
BG24.11.2016
NO24.11.2016
GR25.11.2016
LU15.12.2016
PT26.12.2016
Former [2018/29]HU15.12.2009
AT24.08.2016
BE24.08.2016
CY24.08.2016
CZ24.08.2016
DK24.08.2016
EE24.08.2016
FI24.08.2016
HR24.08.2016
LT24.08.2016
LV24.08.2016
MC24.08.2016
MK24.08.2016
NL24.08.2016
PL24.08.2016
RO24.08.2016
SE24.08.2016
SI24.08.2016
SK24.08.2016
SM24.08.2016
TR24.08.2016
BG24.11.2016
NO24.11.2016
GR25.11.2016
LU15.12.2016
PT26.12.2016
Former [2018/28]HU15.12.2009
AT24.08.2016
BE24.08.2016
CY24.08.2016
CZ24.08.2016
DK24.08.2016
EE24.08.2016
FI24.08.2016
HR24.08.2016
LT24.08.2016
LV24.08.2016
MC24.08.2016
MK24.08.2016
NL24.08.2016
PL24.08.2016
RO24.08.2016
SE24.08.2016
SI24.08.2016
SK24.08.2016
SM24.08.2016
BG24.11.2016
NO24.11.2016
GR25.11.2016
LU15.12.2016
PT26.12.2016
Former [2017/49]AT24.08.2016
BE24.08.2016
CZ24.08.2016
DK24.08.2016
EE24.08.2016
FI24.08.2016
HR24.08.2016
LT24.08.2016
LV24.08.2016
MC24.08.2016
NL24.08.2016
PL24.08.2016
RO24.08.2016
SE24.08.2016
SI24.08.2016
SK24.08.2016
SM24.08.2016
BG24.11.2016
NO24.11.2016
GR25.11.2016
LU15.12.2016
PT26.12.2016
Former [2017/45]AT24.08.2016
BE24.08.2016
CZ24.08.2016
DK24.08.2016
EE24.08.2016
FI24.08.2016
HR24.08.2016
LT24.08.2016
LV24.08.2016
MC24.08.2016
NL24.08.2016
PL24.08.2016
RO24.08.2016
SE24.08.2016
SI24.08.2016
SK24.08.2016
SM24.08.2016
BG24.11.2016
NO24.11.2016
GR25.11.2016
PT26.12.2016
Former [2017/37]AT24.08.2016
BE24.08.2016
CZ24.08.2016
DK24.08.2016
EE24.08.2016
FI24.08.2016
HR24.08.2016
LT24.08.2016
LV24.08.2016
NL24.08.2016
PL24.08.2016
RO24.08.2016
SE24.08.2016
SI24.08.2016
SK24.08.2016
SM24.08.2016
BG24.11.2016
NO24.11.2016
GR25.11.2016
PT26.12.2016
Former [2017/32]AT24.08.2016
BE24.08.2016
CZ24.08.2016
DK24.08.2016
EE24.08.2016
FI24.08.2016
HR24.08.2016
LT24.08.2016
LV24.08.2016
NL24.08.2016
PL24.08.2016
RO24.08.2016
SE24.08.2016
SK24.08.2016
SM24.08.2016
BG24.11.2016
NO24.11.2016
GR25.11.2016
PT26.12.2016
Former [2017/13]AT24.08.2016
FI24.08.2016
HR24.08.2016
LT24.08.2016
LV24.08.2016
NL24.08.2016
SE24.08.2016
NO24.11.2016
GR25.11.2016
PT26.12.2016
Former [2017/11]AT24.08.2016
FI24.08.2016
HR24.08.2016
LT24.08.2016
NL24.08.2016
SE24.08.2016
NO24.11.2016
GR25.11.2016
PT26.12.2016
Former [2017/10]FI24.08.2016
HR24.08.2016
LT24.08.2016
NL24.08.2016
SE24.08.2016
NO24.11.2016
Former [2017/09]FI24.08.2016
LT24.08.2016
NL24.08.2016
NO24.11.2016
Former [2017/07]LT24.08.2016
Cited inInternational search[YD]WO03028720  (PHARMACIA ITALIA SPA [IT], et al) [YD] 1-27 * claims 1, 9, 12, 13, 23 *;
 [YA]WO03051847  (SMITHKLINE BEECHAM PLC [GB], et al) [Y] 7 * claim 1 * * claim 4 *[A] 1-6,8-27;
 [A]WO03078403  (AVENTIS PHARMA SA [FR], et al) [A] 1-27 * claims 1, 9-12 *;
 [Y]WO2008074749  (NERVIANO MEDICAL SCIENCES SRL [IT], et al) [Y] 1-27 * claims 1, 18, 19 * * compounds 214, 218, 202 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.